
浏览全部资源
扫码关注微信
1.110840 沈阳,中国医科大学研究生院
2.110016 沈阳,北部战区总医院心血管外科
[ 王辉山,E-mail:huishanw@126.com WANG Huishan, E-mail: huishanw@126.com
收稿:2020-11-19,
修回:2020-12-22,
纸质出版:2021-01-30
移动端阅览
岳凤捷, 金岩, 尹宗涛, 等. 终末期心房颤动的外科瓣膜手术疗效评价[J]. 第三军医大学学报, 2021,43(2):117-123.
Fengjie YUE, Yan JIN, Zongtao YIN, et al. Efficacy of surgical valve surgery for end stage atrial fibrillation: a report of 693 cases[J]. Journal of Third Military Medical University, 2021, 43(2): 117-123.
岳凤捷, 金岩, 尹宗涛, 等. 终末期心房颤动的外科瓣膜手术疗效评价[J]. 第三军医大学学报, 2021,43(2):117-123. DOI: 10.16016/j.1000-5404.202011185.
Fengjie YUE, Yan JIN, Zongtao YIN, et al. Efficacy of surgical valve surgery for end stage atrial fibrillation: a report of 693 cases[J]. Journal of Third Military Medical University, 2021, 43(2): 117-123. DOI: 10.16016/j.1000-5404.202011185.
目的
2
分析终末期心房颤动患者的临床及超声诊断要点,总结其中采用外科瓣膜手术干预的患者术后中远期疗效。
方法
2
回顾性分析2012年1月至2019年6月北部战区总医院心血管外科693例心脏超声诊断为“心房颤动”患者,根据房室瓣反流的不同情况,分为4组,A组为二尖瓣和/或三尖瓣微量或轻度关闭不全,B组仅以三尖瓣中度及以上关闭不全,C组仅以二尖瓣中度及以上关闭不全,D组为二尖瓣及三尖瓣均有中度及以上关闭不全。后3组患者共计505例,其中124例患者进行了心脏瓣膜手术治疗。
结果
2
693例患者房室瓣反流的程度不断变化,有65例患者经内科治疗后反流程度减轻,其中23例进行了内科房颤射频消融术;505例患者房室瓣反流加重。房室瓣反流程度较重患者中未手术组的
房颤病史明显长于手术组,左室内径明显大于手术组,左室收缩和舒张功能也低于手术组(
P
<
0.05);124例外科手术患者中围术期死亡1例,余随访6~94个月,平均随访时间为63.03(54.61~71.44)个月。配对分析发现术后各房室内径均明显减小(
P
<
0.001),心功能分级明显改善(
P
<
0.001),焦虑自评量表(Self-rating Anxiety Scale
SAS)评分明显下降(
P
<
0.001);尽管部分患者(24例)术后出现LVEF降低,但差异尚无统计学意义(
P
=0.067)。16例瓣膜手术同时行迷宫术,87.5%(14/16)恢复并维持窦性心律;单纯行瓣膜手术107例,16.8%(18/107)可恢复并维持窦性心律。
结论
2
房室瓣大量反流的终末期房颤患者应积极行外科瓣膜手术治疗,手术风险小且可获得良好的生活质量。
Objective
2
To summarize the mid- and long-term curative efficacy of surgical valve surgery intervention for the patients with end-stage atrial fibrillation by analyzing the main points of clinical and ultrasonic diagnosis.
Methods
2
Clinical data of 693 patients with atrial fibrillation diagnosed by echocardiography admitted to our General Hospital of Northern Theater Command from January 2012 to June 2019 were collected and retrospectively analyzed. According to the regurgitation of atrioventricular valve
they were divided into Group A (slight or mild mitral and/or tricuspid insufficiency)
Group B (moderate or above tricuspid insufficiency)
Group C (moderate or above mitral insufficiency)
and Group D (moderate or above mitral and tricuspid insufficiency). There were total 505 patients in the latter 3 groups
among which 124 underwent heart valve surgery.
Results
2
The severiry of atrioventricular valve regurgitation was constantly changing in the 693 patients. There were 65 patients with reduced reflux after medical treatment
and 23 of them underwent radiofrequency ablation of atrial fibrillation. Atrioventricular regurgitation was aggravated in 505 patients. Among the patients with moderate severe regurgitation
the non-operation patients had significantly longer history of atrial fibrillation
larger left ventricular diameter
and lower left ve
ntricular systolic and diastolic functions than the operation patietns (
P
<
0.05). The 124 patients underwent surgical treatment
but 1 patient died during perioperative period
and the others were followed up from 6 months to 94 months (averagely 63.03 months
54.61 to 71.44 months). Paired analysis showed that suegical treatment resulted in significantly decreased diameter of each atrium (
P
<
0.001)
improved cardiac function classification (
P
<
0.001)
and reduced score of Self-rating Anxiety Scale (SAS
P
<
0.001). Although some patients (24 cases) had lower LVEF after operation
there was no significant difference (
P
=0.067). The sinus rhythm was restored and maintained in 14 (87.5%) of 16 patients who underwent valve surgery at the same time
and 18 (16.8%) of 107 patients underwent valve surgery alone.
Conclusion
2
Surgical valve surgery should be carried out actively for the patients with end-stage atrial fibrillation with massive atrioventricular valve regurgitation
with the advantages of low risk and good quality of life.
KANNEL W B, WOLF P A, BENJAMIN E J, et al . Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11 Reprints are not available[J ] . Am J Cardiol, 1998, 82(7): 2N-9N. DOI: 10.1016/s0002-9149(98)00583-9.
HEERINGA J, VAN DER KUIP D A M, HOFMAN A, et al . Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study[J ] . Eur Heart J, 2006, 27(8): 949-953. DOI: 10.1093/eurheartj/ehi825.
SPOSATO L A, CIPRIANO L E, SAPOSNIK G, et al . Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis[J ] . Lancet Neurol, 2015, 14(4): 377-387. DOI: 10.1016/s1474-4422(15)70027-x.
ANGIOLILLO D J, GOODMAN S G, BHATT D L, et al . Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: A north American perspective-2018 update[J ] . Circulation, 2018, 138 (5) : 527-536. DOI: 10.1161/circulationaha.118.034722.
WESTERMAN S, WENGER N. Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes[J]. Curr Cardiol Rev, 2019, 15(2): 136-144. DOI: 10.2174/1573403x15666181205110624.
GASPARINI M, GALIMBERTI P. Atrial fibrillation and cardiac resynchronization therapy[J]. Curr Opin Cardiol, 2018, 33(1): 1-6. DOI: 10.1097/hco.0000000000000472.
MOLTENI M, POLO FRIZ H, PRIMITZ L, et al . The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey[J ] . Europace, 2014, 16(12): 1720-1725. DOI: 10.1093/europace/euu178.
DE CATERINA R, CAMM A J. What is 'valvular' atrial fibrillation? A reappraisal[J]. Eur Heart J, 2014, 35(47): 3328-3335. DOI: 10.1093/eurheartj/ehu352.
FAUCHIER L, PHILIPPART R, CLEMENTY N, et al . How to define valvular atrial fibrillation?[J ] . Arch Cardiovasc Dis, 2015, 108(10): 530-539. DOI: 10.1016/j.acvd.2015.06.002.
DEFERM S, BERTRAND P B, VERBRUGGE F H, et al . Atrial functional mitral regurgitation[J ] . J Am Coll Cardiol, 2019, 73(19): 2465-2476. DOI: 10.1016/j.jacc.2019.02.061.
SILBIGER J J. Mechanistic insights into atrial functional mitral regurgitation: Far more complicated than just left atrial remodeling[J]. Echocardiography, 2019, 36(1): 164-169. DOI: 10.1111/echo.14249.
MACHINO-OHTSUKA T, SEO Y, ISHIZU T, et al . Novel mechanistic insights into atrial functional mitral regurgitation-3-dimensional echocardiographic study[J ] . Circ J, 2016, 80(10): 2240-2248. DOI: 10.1253/circj.cj-16-0435.
MURARU D, GUTA A C, OCHOA-JIMENEZ R C, et al . Functional regurgitation of atrioventricular valves and atrial fibrillation: an elusive pathophysiological link deserving further attention[J ] . J Am Soc Echocardiogr, 2020, 33(1): 42-53. DOI: 10.1016/j.echo.2019.08.016.
LOMBARD F W, LIANG Y. Risk factors for mitral valve surgery: atrial fibrillation and pulmonary hypertension[J]. Semin Cardiothorac Vasc Anesth, 2019, 23(1): 57-69. DOI: 10.1177/1089253218821694.
SERPYTIS R, NAVICKAITE A, SERPYTIENE E, et al . Impact of atrial fibrillation on cognitive function, psychological distress, quality of life, and impulsiveness[J ] . Am J Med, 2018, 131(6): 703.e1-703.e5. DOI: 10.1016/j.amjmed.2017.12.044.
WALTERS T E, WICK K, TAN G, et al . Symptom severity and quality of life in patients with atrial fibrillation: Psychological function outweighs clinical predictors[J ] . Int J Cardiol, 2019, 279: 84-89. DOI: 10.1016/j.ijcard.2018.10.101.
金岩, 张誉籍, 于岩, 等.病因学诊断"心房颤动"患者心脏超声特点及临床应用[J].临床军医杂志, 2020, 48 (6) : 634-637, 648.
JIN Y, ZHANG Y J, YU Y, et al . Echocardiographic features and clinical application of etiological diagnosis in patients with atrial fibrillation[J ] . J Clin Mil Med, 2020, 48 (6) : 634-637, 648.
NISHIMURA R A, TAJIK A J. Quantitative hemodynamicsby Doppler echocardiography: a noninvasive alternative to cardiac catheterization[J]. Prog Cardiovasc Dis, 1994, 36(4): 309-342. DOI: 10.1016/s0033-0620(05)80037-4.
NISHIMURA R A, CARABELLO B. Operationalizing the 2014 ACC/AHA guidelines forvalvular heart disease: a guide for clinicians[J]. J Am Coll Cardiol, 2016, 67(19): 2289-2294. DOI: 10.1016/j.jacc.2016.02.065.
UDO E O, HASSINK R J. Pulmonary vein isolation as a treatment for severe atrial functional mitral regurgitation in a patient with atrial fibrillation[J]. Int J Cardiol, 2014, 175(3): 578-579. DOI: 10.1016/j.ijcard.2014.05.025.
MTOUR S, ROSENMANN D, JUBEH R, et al . Mitral regurgitation improvement after conversion of atrial fibrillation to sinus rhythm[J ] . Eur Heart J, 2013, 34(suppl 1): P4749. DOI: 10.1093/eurheartj/eht310.p4749.
SAVAGE DD, DEVEREUX R B, GARRISON R J, et al . Mitral valve prolapse in the general population. 2. Clinical features: The Framingham Study[J ] . Am Heart J, 1983, 106(3): 577-581. DOI: 10.1016/0002-8703(83)90705-6.
WARTH D C, KING M E, COHEN J M, et al . Prevalence of mitral valve prolapse in normal children[J ] . J Am Coll Cardiol, 1985, 5(5): 1173-1177. DOI: 10.1016/s0735-1097(85)80021-8.
SAVAGE D D, GARRISON R J, DEVEREUX R B, et al . Mitral valve prolapse in the general population. Ⅰ. Epidemiologic features: The Framingham Study[J ] . Am Heart J, 1983, 106(3): 571-576. DOI: 10.1016/0002-8703(83)90704-4.
LEVINE R A, STATHOGIANNIS E, NEWELL J B, et al . Reconsideration of echocardiographic standards for mitral valve prolapse: Lack of association between leaflet displacement iso lated to the apical four chamber view and independent echocardiographic evidence of abnormality[J ] . J Am Coll Cardiol, 1988, 11(5): 1010-1019. DOI: 10.1016/s0735-1097(98)90059-6.
BASSO C, PERAZZOLO MARRA M, RIZZO S, et al . Arrhythmic mitral valve prolapse and sudden cardiac death[J ] . Circulation, 2015, 132(7): 556-566. DOI: 10.1161/circulationaha.115.016291.
BALLESTER M, PRESBITERO P, FOALE R, et al . Prolapse of the mitral valve insecundum atrial septal defect: a functional mechanism[J ] . Eur Heart J, 1983, 4(7): 472-476. DOI: 10.1093/oxfordjournals.eurheartj.a061504.
MA S Y, MA J, TU Q Q, et al . Isoproterenol increases left atrial fibrosis and susceptibility to atrial fibrillation by inducing atrial ischemic infarction in rats[J ] . Front Pharmacol, 2020, 11: 493. DOI: 10.3389/fphar.2020.00493.
MARON B J, DOERER J J, HAAS T S, et al . Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006[J ] . Circulation, 2009, 119(8): 1085-1092. DOI: 10.1161/CIRCULATIONAHA.108.804617.
周自强, 胡大一, 陈捷, 等.中国心房颤动现状的流行病学研究[J].中华内科杂志, 2004 (7): 15-18.
ZHOU Z Q, HU D Y, CHEN J, et al . Epidemiology of atrial fibrillation in China[J ] . Chin J Intern Med, 2004 (7): 15-18.
MACHINO-OHTSUKA T, SEO Y, ISHIZU T, et al . Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction[J ] . J Am Coll Cardiol, 2013, 62(20): 1857-1865. DOI: 10.1016/j.jacc.2013.07.020.
金岩, 王辉山, 汪曾炜, 等.心房颤动对不同病因的二尖瓣手术治疗预后的影响[J].中华胸心血管外科杂志, 2014, 30(4): 213-217.
JIN Y, WANG H S, WANG Z W, et al . The influence of atrial fibrillation on prognosis after mitral valve surgery in rheumatic mitral valve Stenosis and mitral valve prolapse patients[J ] . Chin J Thorac Cardiovasc Surg, 2014, 30(4): 213-217.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621